Cell Biology

Latest Content

How COVID-19 kills: a tale of two conditions

Steve Walton, explains why he believes the majority of patients that die after being infected with SARS CoV-2 virus infection do not die from respiratory failure, but because of a systemic multi orga…

News

Computational model could help translate drugs from animal studies to human

About 50% of people who take the drug infliximab for inflammatory bowel diseases, such as Crohn's disease, end up becoming resistant or unresponsive to it.

Scientists might be able to catch problems…

In Depth

Knowing a lot about very little

The potential of nanomedicine to tackle many diseases is immense, but we really don’t know much about how they get into cells and what potential damage – as well as good – they could do. Here we lear…

Comment And Analysis

How COVID-19 kills: a tale of two conditions

Steve Walton, explains why he believes the majority of patients that die after being infected with SARS CoV-2 virus infection do not die from respiratory failure, but because of a systemic multi orga…

Interviews

A question of reagents

At the time of writing, more than 1.3M people have been infected and more than 72,600 deaths have been linked to the current outbreak of coronavirus. We caught up with Trey Martin, President, of spec…